Results 101 to 110 of about 21,987 (211)

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

open access: yesMolecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis   +3 more
wiley   +1 more source

MechRAG: a multimodal large language model for mechanical engineering

open access: yesCommunications Engineering
Engineering design and manufacture are inherently multimodal activities in which engineers consult and produce diverse data and representations across various engineering disciplines and product lifecycle stages. Although well-established digital formats
Shuang Li, Jonathan Corney
doaj   +1 more source

Computer-Aided Design in Mechanical Engineering: Insights and Future Directions from a Special Issue

open access: yesApplied Sciences
The discipline of mechanical engineering (ME) relies on digital architecture provided by Computer-Aided Design (CAD) [...]
Rocco Furferi
doaj   +1 more source

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

International conference on computer-aided production engineering

open access: yes, 1986
SIGLEAvailable from British Library Document Supply Centre- DSC:86/16167(International) / BLDSC - British Library Document Supply CentreGBUnited ...
McGeough, J.A. (ed.)   +3 more
core  

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

Construction of a Cutting-Tool Wear Prediction Model through Ensemble Learning

open access: yesApplied Sciences
This study begins by conducting side milling experiments on SKD11 using tungsten carbide TiAlN-coated end mills to compare the surface roughness performance between two combinations of milling process parameters (feed rate and radial depth of cut), along
Shen-Yung Lin, Chia-Jen Hsieh
doaj   +1 more source

MITF maintains genome stability in nonmelanocyte lineages

open access: yesMolecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir   +13 more
wiley   +1 more source

Stiffness and Lightweight Enhancement in Biomimetic Design of a Grinding Machine-Tool Structure

open access: yesApplied Sciences
As global manufacturing faces rising energy costs, environmental pressures, and machining precision, the development trends of the machine tools are moving towards lightweight and high-rigidity structures.
Shen-Yung Lin, Yen-Ting Lai
doaj   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy